John Sarbanes actually said...

So you're taking a very broad perspective, which I think is the prudent one to do.

I don't think it's a good idea to move these OPM functions into those three agencies as has been proposed.

I think if you look at the impact on the public of drug prices, it is hard to argue that it isn't as extensive and permeating as those other...

Well, that is going to be subject to debate and whatever, but you are going to get a period of exclusivity.